Newswise

Published October 9, 2026

Psilera Greenlit to Initiate Phase 2 of NIH Grant for Alcohol Use Disorder | Newswise

Read the full story at Newswise

Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies,.